Please wait while we open this resource.
K
Clinical reviews
PHARMACOTHERAPY OF HEART FAILURE A.D. 2023
Medical University of Lodz, Collegium Medicum Jan Kochanowski University, Maria Skłodowska-Curie Medical Academy, Medical University of Warsaw, Świętokrzyskie Cardiology Center
PDF202320 pages1.8 MB
Heart failure (HF) remains one of the most common causes of morbidity and mortality worldwide. This expert opinion document from the Working Group on Cardiovascular Pharmacotherapy of the Polish Cardiac Society discusses the latest pharmacological treatments for HF, including new drug therapies and their clinical implications. It emphasizes the importance of individualized treatment strategies and the integration of recent clinical trial findings into practice.
Sign in to open
Ask this resource
Answers use this document only.
Your first question is free.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
SURVIVAL AFTER INITIAL STRESS TESTING VS ANATOMIC TESTING IN SUSPECTED CORONARY ARTERY DISEASE
Same clinical topic · Cardiology
PRACTICAL CARDIO-ONCOLOGY
Same clinical topic · Cardiology
OXFORD CARDIOLOGY LIBRARY: Hypertension
Same clinical topic · Cardiology
CARDIAC INVOLVEMENT IN PARASITIC INFECTIONS
Same clinical topic · Cardiology
The Athlete’s ECG
Same clinical topic · Cardiology
Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review
Same clinical topic · Cardiology
Current ECG Aspects of Interatrial Block
Same clinical topic · Cardiology
Arrhythmic mitral valve prolapse in 2023: Evidence-based update
Same clinical topic · Cardiology
INTERPRETING THE NORMAL PACEMAKER
Same clinical topic · Cardiology